comparemela.com

Latest Breaking News On - Its lentivector - Page 1 : comparemela.com

JPMorgan Chase & Co Cuts Oxford Biomedica (OTCMKTS:OXBDF) Price Target to GBX 325

JPMorgan Chase & Co Cuts Oxford Biomedica (OTCMKTS:OXBDF) Price Target to GBX 325
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Oxford Biomedica (OTCMKTS:OXBDF) Given New GBX 325 Price Target at JPMorgan Chase & Co

Oxford Biomedica (OTCMKTS:OXBDF – Free Report) had its price objective reduced by JPMorgan Chase & Co. from GBX 495 ($6.13) to GBX 325 ($4.03) in a research note issued to investors on Friday, FlyOnTheWall reports. Several other equities research analysts have also issued reports on the stock. Liberum Capital lowered shares of Oxford Biomedica from […]

Oxford Biomedica (OTCMKTS:OXBDF) Price Target Cut to GBX 325 by Analysts at JPMorgan Chase & Co

Oxford Biomedica (OTCMKTS:OXBDF – Get Free Report) had its price target cut by stock analysts at JPMorgan Chase & Co. from GBX 495 ($6.13) to GBX 325 ($4.03) in a research report issued on Friday, FlyOnTheWall reports. Several other research firms have also recently weighed in on OXBDF. Stifel Nicolaus cut shares of Oxford Biomedica […]

Oxford Biomedica (OTCMKTS:OXBDF) Shares Down 1 4%

Oxford Biomedica (OTCMKTS:OXBDF) Shares Down 1 4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Update

Oxford Biomedica plc (OTCMKTS:OXBDF – Get Free Report) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 71,700 shares, a growth of 21.9% from the June 30th total of 58,800 shares. Based on an average daily volume of 100 shares, […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.